However, aberrant TNFR2 expression was also reported for tumor cells; for example, in esophageal squamous cell carcinoma [118], colorectal cancer [119,120], ovarian cancer [121], Hodgkin’s and non-Hodgkin’s lymphomas [122,123], and renal cell carcinoma [124,125]. This evidence concerns the gene TNFRSF1B and neoplasm.